Meditor Group Ltd
CIK
1382333
Location
HAMILTON, D0
Portfolio Value
Micro
$41,611,222
Diversification
Highly concentrated
Filing Date
Global Rank
#6,209
/ 7,303
▼ 205
Top Industry
Biotechnology
85.0%
3Y Alpha vs SPY
+17.4%
Period ended 1 year ago
Filed Oct 7, 2024 · 1y
19 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+164.4%
SPY
+76.5%
Annualised alpha
+17.4%
Max drawdown
−20.0%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Sep 30, 2024 · Δ vs Jun 30, 2024Top Position
85.0%
+2.6 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
7,445
Highly concentrated+347
Portfolio Trend
19 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $41,611,222 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| EXEL | Exelixis, Inc. | −390,550 | 1,362,450 | $35,355,577 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
2 positions ·
$41,611,222 total
· as of Sep 30, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EXEL |
Exelixis, Inc.
Healthcare
|
Reduced | 1,362,450 | $35,355,577 | 84.97% | |
| ESPR |
Esperion Therapeutics, Inc.
Healthcare
|
Held | 3,791,300 | $6,255,645 | 15.03% |